- Home
- PRI vs JAZZ Comparison
PRI vs JAZZ Comparison
Compare PRI & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRI
- JAZZ
- Stock Information
- Founded
- PRI 1927
- JAZZ 2003
- Country
- PRI United States
- JAZZ Ireland
- Employees
- PRI N/A
- JAZZ N/A
- Industry
- PRI Life Insurance
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- PRI Finance
- JAZZ Health Care
- Exchange
- PRI Nasdaq
- JAZZ Nasdaq
- Market Cap
- PRI 8.5B
- JAZZ 7.9B
- IPO Year
- PRI N/A
- JAZZ 2007
- Fundamental
- Price
- PRI $272.35
- JAZZ $136.58
- Analyst Decision
- PRI Buy
- JAZZ Strong Buy
- Analyst Count
- PRI 7
- JAZZ 14
- Target Price
- PRI $316.00
- JAZZ $179.21
- AVG Volume (30 Days)
- PRI 191.5K
- JAZZ 758.5K
- Earning Date
- PRI 11-05-2025
- JAZZ 11-05-2025
- Dividend Yield
- PRI 1.53%
- JAZZ N/A
- EPS Growth
- PRI 61.36
- JAZZ N/A
- EPS
- PRI 20.26
- JAZZ N/A
- Revenue
- PRI $3,220,913,000.00
- JAZZ $4,086,695,000.00
- Revenue This Year
- PRI $4.38
- JAZZ $5.70
- Revenue Next Year
- PRI $5.62
- JAZZ $6.16
- P/E Ratio
- PRI $13.46
- JAZZ N/A
- Revenue Growth
- PRI 7.56
- JAZZ 4.52
- 52 Week Low
- PRI $230.98
- JAZZ $95.49
- 52 Week High
- PRI $307.91
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- PRI 47.95
- JAZZ 63.56
- Support Level
- PRI $273.24
- JAZZ $125.79
- Resistance Level
- PRI $281.70
- JAZZ $140.39
- Average True Range (ATR)
- PRI 6.30
- JAZZ 3.18
- MACD
- PRI -0.39
- JAZZ 0.46
- Stochastic Oscillator
- PRI 18.55
- JAZZ 71.59
About PRI Primerica Inc.
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.